— Longtime tech executive Liz Pearce announced Monday that she is joining Seattle-based climate marketplace startup Ever.green as chief revenue officer. Pearce said she was motivated to make the career… Read More
— Sarah Korman, chief legal officer at Vancouver, Wash.-based biotech company Absci, will depart Sept. 15, according to a regulatory filing. The company, which is developing technologies to accelerate the… Read More
— Hootsuite appointed Elina Vilk as chief marketing officer. Vilk previously worked as CMO at Woocommerce, an open-source e-commerce plugin for WordPress sites. She also held marketing leadership roles at… Read More
We’re inside the headquarters of Outpace Bio in Seattle. Senior scientist Bobby Langan shows a video of one of his favorite deep-learning tools, used to create experimental cancer therapeutics. A… Read More
— Vancouver, Wash.-based AI drug design and development company Absci named Frans van Houten to its board of directors. A longtime business exec, van Houten is known for spearheading Philips’… Read More
Vancouver, Wash.-based drug design and development company Absci laid off employees Tuesday, a little more than a year after going public. “The macro-economic conditions of the last few months prompted… Read More
— Vimeo appointed Lynn Girotto as chief marketing officer and Ashraf Alkarmi as chief product officer for the New York City video software company. Both will be based in the… Read More
Absci, the Vancouver, Wash.-based biotech that provides drug and drug target discovery services to other companies, has opened a lab in New York City. The company announced the opening of… Read More
—Michael Panzara, chief medical officer and head of therapeutics discovery and development for Wave Life Sciences, was appointed to Athira Pharma’s board of directors. Panzara has more than 20 years… Read More
— Chad Cohen will step down as CFO of Adaptive Biotechnologies on Feb. 15. Prior to joining Adaptive in 2015, Cohen was CFO of Zillow Group. Principal accounting officer Kyle… Read More
Absci cut the ribbon on its new headquarters in Vancouver, Wash., on Tuesday, barely three months after going public in an IPO that valued the biotech company at nearly $2… Read More
— IoT startup Mason announced that founder and current CEO Jim Xiao will be swapping roles with his sister and current Mason President Nancy Xiao. “I’m confident that Nancy is… Read More
Biotech CEOs tend to have advanced degrees and multiple academic credentials under their belt. But Sean McClain started Absci as a freshly minted grad from the University of Arizona at… Read More
Shares of Absci surged more than 30% on Thursday as the Vancouver, Wash.-based biotech company made its debut as a public company. Absci priced its stock at $16 per share… Read More
The upcoming public offering for Vancouver, Wash.-based biotech company Absci reflects a soaring IPO market and adds to the growing prosperity of Pacific Northwest biotech companies. The company’s success also… Read More
— Biotech company Absci, which filed to go public last week, added Nikhil Goel as chief business officer and Sarah Korman as general counsel. Goel was previously an investment banker… Read More
Absci, a Vancouver, Wash.-based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. The company’s platform is built… Read More
New funding: Vancouver, Wash.-based biotech company AbSci raised $125 million in a round led by Casdin Capital and Redmile Group. The tech: Founded in 2011, AbSci’s “Protein Printing” technology is used… Read More
AbSci has acquired Denovium, a 6-person bootstrapped startup out of San Diego that uses deep learning to analyze the function and behavior of proteins. The deal will help bolster AbSci’s… Read More
Vancouver, Wash.-based biotech company AbSci raised an additional $65 million to help grow its synthetic biology platform. The company’s “Protein Printing” technology is used to discover and manufacture complex biological… Read More
Vancouver, Wash.,-based biotechnology company AbSci has raised a chunk of new money. The company announced Wednesday that it has just completed an oversubscribed $12 million Series C round of funding.… Read More
